CAN

Cann Group Limited

1 day chart

About CAN

Cann Group Limited (CAN) is involved in cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licences and permits issued to the Company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.

Buy Australian shares starting with CAN. Invest today with a CHESS-sponsored investing platform!

Sector

Health Care

CEO

Mr Peter Koetsier

Industry

Pharmaceuticals

Website

canngrouplimited.com

Market Capitalisation

$51M

Price-earnings ratio

-1.35

Dividend yield

NaN%

High today

$0.13

Low today

$0.12

Open price

$0.13

52-week high

$0.30

52-week low

$0.11

Announcements

CAN FAQs

Can I buy CAN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CAN shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Cann Group Limited?

One share of Cann Group Limited is valued at $0.12.

What is the ticker symbol for Cann Group Limited?

The ticker symbol for Cann Group Limited is CAN.

How do I buy CAN shares in Australia?

To buy CAN stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in CAN

What is the 52-week high for Cann Group Limited stock?

The Cann Group Limited 52-week high stock price is $0.30.

What is the 52-week low for Cann Group Limited stock?

The Cann Group Limited 52-week low stock price is $0.11.

What is the market capitalisation of Cann Group Limited CAN?

As of 21/09/2023 Cann Group Limited has a market cap of $51M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.